Data & Analytics
Identify, Segment, and
Target the Right HCPs
Find and reach more providers with the right data foundation.
30%
of KOLs have no recorded interactions with MSLs
53
mergers and acquisitions in 2022 alone
81 %
of pharmas have moderate to no visibility into HCP/HCO relationships
Sources: Veeva Pulse, Avalere, Veeva
Improve segmentation and targeting with connected data
Learn how one top pharma leveraged four connected data sets to develop a unified HCP target list.
![](https://www.veeva.com/wp-content/uploads/2023/01/Understanding-Patient-Journeys-for-Launch-tile.png)
“When you have clean, fast data, you can have better analytics. This is how we are driving more precision engagement.”
![Novartis](/wp-content/themes/veeva2015/assets/veeva-2024/logos/color/novartis.png)
![](https://www.veeva.com/eu/wp-content/uploads/2022/11/Profile_Elodie-Privat.png)
Elodie Privat
Sales Analytics and Operations Lead, Novartis Gene Therapies
Tips & Insights
How biopharma leaders identify
and prioritize KOLs and HCPs
HCP segmentation and targeting solutions
Prioritize the right HCPs with connected customer, patient, prescriber, and KOL data.